Table II.
Expression of HPV16 E7 and COX-2 in invasive ductal breast cancer.
| Sample | Sex | Ct GAPDH (mean ± SD) | Ct of HPV16E7 (mean ± SD) | Ct of COX-2 (mean ± SD) |
|---|---|---|---|---|
| 1 | Female | 25.15±0.07 | Undetermined | 27.56±0.43 |
| 2 | Female | 24.27±0.18 | 25.53±0.29 | 23.62±0.23 |
| 3 | Female | 25.51±0.32 | Undetermined | 27.68 ±0.39 |
| 4 | Female | 23.55±0.18 | 24.29±0.09 | 21.38±0.38 |
| 5 | Female | 26.42±0.23 | 27.58±0.31 | 25.36±0.24 |
| 6 | Female | 26.09±0.32 | Undetermined | 28.29±0.10 |
| 7 | Female | 28.07±0.07 | Undetermined | 27.18±0.11 |
| 8 | Female | 24.58±0.20 | 22.22±0.04 | 23.22±0.19 |
| 9 | Female | 26.94±0.05 | Undetermined | 29.52±0.18 |
| 10 | Female | 27.59±0.50 | Undetermined | 25.67±0.34 |
| 11 | Female | 25.07±0.27 | Undetermined | 27.77±0.35 |
| 12 | Female | 29.35±0.16 | Undetermined | 28.77±0.44 |
| 13 | Female | 25.06±0.12 | Undetermined | 27.53±0.41 |
| 14 | Female | 21.30±0.21 | Undetermined | 26.64±0.91 |
| 15 | Female | 25.44±0.26 | Undetermined | 27.56±0.29 |
| 16 | Female | 24.33±0.15 | 32.17±0.03 | 24.21±0.17 |
| 17 | Female | 26.49±0.30 | Undetermined | 28.32±0.21 |
| 18 | Female | 26.28±0.19 | 28.16±0.05 | 24.42±0.15 |
| 19 | Female | 28.28±0.22 | Undetermined | 27.30±0.10 |
| 20 | Female | 27.51±0.40 | Undetermined | 28.52±0.18 |
| 21 | Female | 26.62±0.20 | 33.21±0.05 | 26.44±0.20 |
| 22 | Female | 27.60±0.50 | Undetermined | 26.52±0.23 |
| 23 | Female | 24.57±0.23 | Undetermined | 27.58±0.21 |
| 24 | Female | 29.44±0.23 | Undetermined | 29.13±0.18 |
| 25 | Female | 25.67±0.17 | Undetermined | 24.55±0.37 |
| 26 | Female | 24.67±0.20 | 25.32±0.27 | 22.33±0.17 |
| 27 | Female | 27.36±0.15 | Undetermined | 27.52±0.37 |
| 28 | Female | 25.19±0.13 | 30.27±0.13 | 24.12±0.03 |
| 29 | Female | 29.34±0.27 | Undetermined | 27.19±0.29 |
| 30 | Female | 25.52±0.26 | 28.13±0.10 | 23.56±0.28 |
| 31 | Female | 24.81±0.15 | Undetermined | 24.15±0.09 |
| 32 | Female | 26.41±0.19 | Undetermined | 27.45±0.31 |
| 33 | Female | 23.28±0.10 | Undetermined | 21.67±0.10 |
| 34 | Female | 28.76±0.30 | Undetermined | 28.29±0.15 |
| 35 | Female | 24.54±0.28 | 24.18±0.03 | 22.59±0.13 |
| 36 | Female | 29.60±0.36 | Undetermined | 29.33±0.29 |
| 37 | Female | 27.57±0.31 | Undetermined | 26.47±0.15 |
| 38 | Female | 29.82±0.03 | Undetermined | 29.21±0.04 |
| 39 | Female | 24.70±0.18 | 33.20±0.08 | 22.49±0.35 |
| 40 | Female | 22.80±0.16 | 26.53±0.29 | 21.59±0.11 |
| 41 | Female | 26.29±0.18 | Undetermined | 25.67±0.10 |
| 42 | Female | 27.37±0.48 | Undetermined | 26.29±0.15 |
| 43 | Female | 27.95±0.02 | Undetermined | 26.59±0.13 |
| 44 | Female | 30.49±0.17 | Undetermined | 30.39±0.23 |
| 45 | Female | 26.27±0.42 | Undetermined | 24.74±0.55 |
| 46 | Female | 27.44±0.34 | Undetermined | 27.24±0.22 |
| 47 | Female | 29.74±0.16 | Undetermined | 29.38±0.24 |
| 48 | Female | 22.42±0.25 | 30.58±0.31 | 21.32±0.22 |
| 49 | Female | 23.71±0.20 | 35.29±0.09 | 23.45±0.22 |
| 50 | Female | 23.61±0.44 | 27.18±0.01 | 25.42±0.52 |
| 51 | Female | 25.12±0.05 | Undetermined | 25.39±0.10 |
| 52 | Female | 26.46±0.31 | Undetermined | 26.72±0.33 |
| 53 | Female | 27.41±0.25 | Undetermined | 27.65±0.28 |
| 54 | Female | 29.14±0.12 | Undetermined | 29.22±0.14 |
| 55 | Female | 22.97±0.03 | 23.37±0.23 | 21.61±0.12 |
| 56 | Female | 26.81±0.16 | 29.31±0.15 | 25.27±0.12 |
| 57 | Female | 28.49±0.22 | Undetermined | 30.46±0.46 |
| 58 | Female | 26.10±0.02 | Undetermined | 24.57±0.31 |
| 59 | Female | 25.44±0.43 | Undetermined | 26.15±0.18 |
HPV, human papilloma virus; COX-2, cyclooxygenase-2; SD, standard deviation.